INTELLECTUAL PROPERTY
Allozyne’s intellectual property provides a robust foundation that validates our technology and lead assets. We have academic and corporate partners that complement our global intellectual property strategy. Our platform and product IP portfolio includes patents and patent applications covering:
- Bioconjugation of Polyethylene glycol (PEG) or other biopolymers
- Methods of incorporating amino acid analogs
- Protein based diagnostics and therapeutics
- Pharmacokinetic enhancement
- Specific chemistries
- Computational methods
We have filed or licensed many patents or patent applications in the U.S. and abroad, including foreign counterparts of some of these applications in Australia, Canada, Europe, Japan and other countries.